Targeting IL-4 for the Treatment of Atopic Dermatitis

被引：0
|
作者：
Chiricozzi, Andrea [1 ,2 ]
Maurelli, Martina [3 ]
Peris, Ketty [1 ,2 ]
Girolomoni, Giampiero [3 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, Dermatol, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dermatol, Rome, Italy
[3] Univ Verona, Dept Med, Sect Dermatol, Verona, Italy
来源：
IMMUNOTARGETS AND THERAPY | 2020年 / 9卷
关键词：
atopic dermatitis; IL-4; inhibitor; dupilumab; pascolizumab; pitrakinra; TH2; CYTOKINES; STAPHYLOCOCCUS-AUREUS; DERMAL FIBROBLASTS; DENDRITIC CELLS; TRANSGENIC MICE; LESIONAL SKIN; UP-REGULATION; IFN-GAMMA; IN-VITRO; T-CELLS;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Atopic dermatitis (AD) is an immune-mediated inflammatory skin disease characterized by a predominant type 2 immune response. Type 2 immunity is driven by multiple cytokines, including interleukin (IL)-4 and IL-13 that are considered central to AD pathogenesis and key therapeutic targets. The dual inhibition of these two cytokines or the selective inhibition of IL-13 proved elevated efficacy in treating AD, whereas the selective inhibition of IL-4 has been poorly investigated as IL-4 inhibiting agents did not show any advance in clinical development programs. This review describes the pathogenic role of IL-4 in AD and briefly resumes the main features of compounds selectively blocking IL-4.
引用
收藏
页码：151 / 156
页数：6
相关论文
共 50 条
  • [21] From Bench to Clinic: the Potential of Therapeutic Targeting of the IL-22 Signaling Pathway in Atopic Dermatitis
    Jin, Mirim
    Yoon, Juhan
    IMMUNE NETWORK, 2018, 18 (06)
  • [22] Echinochrome A Treatment Alleviates Atopic Dermatitis-like Skin Lesions in NC/Nga Mice via IL-4 and IL-13 Suppression
    Yun, Hyeong Rok
    Ahn, Sang Woo
    Seol, Bomin
    Vasileva, Elena A.
    Mishchenko, Natalia P.
    Fedoreyev, Sergey A.
    Stonik, Valentin A.
    Han, Jin
    Ko, Kyung Soo
    Rhee, Byoung Doo
    Seol, Jung Eun
    Kim, Hyoung Kyu
    MARINE DRUGS, 2021, 19 (11)
  • [23] Dysregulated microRNA expression in IL-4 transgenic mice, an animal model of atopic dermatitis
    Bao, Lei
    Chau, Cecilia S.
    Lei, Zhengdeng
    Hu, Hong
    Chan, Angelina G.
    Amber, Kyle T.
    Maienschein-Cline, Mark
    Tsoukas, Maria M.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2021, 313 (10) : 837 - 846
  • [24] Dysregulated microRNA expression in IL-4 transgenic mice, an animal model of atopic dermatitis
    Lei Bao
    Cecilia S. Chau
    Zhengdeng Lei
    Hong Hu
    Angelina G. Chan
    Kyle T. Amber
    Mark Maienschein-Cline
    Maria M. Tsoukas
    Archives of Dermatological Research, 2021, 313 : 837 - 846
  • [25] Association between genes encoding components of the IL-4/IL-4 receptor pathway and dermatitis in children
    Hussein, Yousri M.
    Shalaby, Sally M.
    Nassar, Arnani
    Alzahrani, Saad S.
    Alharbi, Ayman S.
    Nouh, Maha
    GENE, 2014, 545 (02) : 276 - 281
  • [26] Commonality of the IL-4/IL-13 pathway in atopic diseases
    Gandhi, Namita A.
    Pirozzi, Gianluca
    Graham, Neil M. H.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (05) : 425 - 437
  • [27] Treatment of Atopic Dermatitis with Biologic Drugs
    Fabbrocini, Gabriella
    Napolitano, Maddalena
    Megna, Matteo
    Balato, Nicola
    Patruno, Cataldo
    DERMATOLOGY AND THERAPY, 2018, 8 (04) : 527 - 538
  • [28] GB12-09, a bispecific antibody targeting IL4Rα and IL31Rα for atopic dermatitis therapy
    Deng, Feiyan
    Qiu, Yuxin
    Zhang, Xiangling
    Guo, Nining
    Hu, Junhong
    Yang, Wenjie
    Shang, Wei
    Liu, Bicheng
    Qin, Suofu
    ANTIBODY THERAPEUTICS, 2024, 7 (01) : 77 - 87
  • [29] IL-13 antagonists in the treatment of atopic dermatitis
    Tubau, Carla
    Puig, Lluis
    IMMUNOTHERAPY, 2021, 13 (04) : 327 - 344
  • [30] Unique profile of IL-4 and IFN-γ production by peripheral blood mononuclear cells in infants with atopic dermatitis
    Kimura, M
    Tsuruta, S
    Yoshida, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (02) : 238 - 244
12345